ZORBAX 300SB-CN 5um, 2.1 x 150mm
Order number: 883750-905
Part number: AC100093921
Price Breakdown
Configured for stable performance in synthesis settings, the ZORBAX 300Sb-Cn 5Um column is designed for use in liquid chromatography (LC), including LC/MS techniques. This reversed phase column features a pore size of 300 Å and a particle size of 5 μm, making it suitable for separating peptides, proteins, and monoclonal antibodies (mABs) within the biopharma industry. The column's hardness is SS, and it operates effectively over a wide pH range of 1-8. With a maximum operating temperature of 80°C and a pressure rating of 400 bar, this ZORBAX StableBond column ensures reliable separation under various conditions. The column is supplied with acetonitrile/water as the shipping solvent, and its inner diameter measures 2.1 mm, while the length is 150 mm.
- Category: ZORBAX StableBond
- LC Column Phase: 300SB-CN
- Pore Size: 300 A
- Particle Type: Fully Porous
- Pressure Rating: 400 bar
- Shipping Solvent: Acetonitrile/Water
- Separation Mode: Reversed Phase
- LC Column Brand: ZORBAX
- pH Range: 1-8
- LC Column Maximum Temperature: 80 C
- Length: 150 mm
- Part Number Application: Peptides, Proteins, Monoclonal Antibodies (mABs)
- UNSPSC 13.5: 41115709
- Technique: LC, LC & LC/MS.
- Part Number Application Domain: Biopharma
- Inner Diameter (ID): 2.1 mm
- Particle Size: 5 um
- Hardware: SS
| Name | Value | |
|---|---|---|
| Length | : | 150 mm |
| Hardware | : | SS |
| pH Range | : | 1-8 |
| Pore Size | : | 300 A |
| Technique | : | LC, LC & LC/MS. |
| UNSPSC 13.5 | : | 41115709 |
| Particle Size | : | 5 um |
| Particle Type | : | Fully Porous |
| LC Column Brand | : | ZORBAX |
| LC Column Phase | : | 300SB-CN |
| Pressure Rating | : | 400 bar |
| Separation Mode | : | Reversed Phase |
| Shipping Solvent | : | Acetonitrile/Water |
| Inner Diameter (ID) | : | 2.1 mm |
| Part Number Application | : | Peptides, Proteins, Monoclonal Antibodies (mABs) |
| LC Column Maximum Temperature | : | 80 C |
| Part Number Application Domain | : | Biopharma |
